Flow Cytometry – News and Features

A CU Anschutz-led team of researchers has discovered the potential function of a previously mysterious cell receptor and is working to determine how best to utilize its signals in developing therapies for lung and intestinal diseases.

Researchers discover novel protein biomarkers to visualize well-developed sperm to determine if surgical sperm extraction may be successful.

Glut1 deficiency syndrome is a rare and disabling neurological disease still relatively unknown to the medical community.

Researchers have uncovered two proteins that are unique to viable sperm, offering men with the most severe form of male infertility both a non-invasive diagnostic test and more information about their chances to one day become a parent through in vitro fertilization.

In a promising development for cancer screening and treatment, groundbreaking research has led to a new laboratory test to measure cell mechanotypes quickly and easily.

Researchers have mapped the gut immune system in children with inflammatory bowel disease (IBD), which could aid in the development of more targeted therapies.

A therapy that harnesses immune cells collected from tumors could be made a more viable option by using circulating tumor-reactive lymphocytes found in the blood to fight tumors.

Researchers have developed a platform that improves accuracy, throughput and stability in profiling the dynamic metabolic features of cells.

This article will present two multiomics vignettes. One involves the search for a deeper understanding of food allergies and a potential path forward for treatment. Another will describe the response to bariatric surgery, a growing need as obesity trends upward in many parts of the world.

Researchers have identified that gamma delta T cells impact the gut microbiome and may affect brain functions linked to stress-induced disorders such as depression.